Arkolith/Insider Trading/BNTC/Form 4

Banks Jerel A.

Chief Executive Officer, DirectorBenitec Biopharma Inc. (BNTC) · full profile →Form 4 · filed Jun 15, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 13, 2023Grant(A)357K—$0357K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-013634) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML